celastrol has been researched along with Dyslipidemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Fang, K; Li, J; Li, L; Lu, F; Luo, J; Lynch, EC; Wu, F; Xie, L; Xu, L; Yang, X; Zhao, Y; Zou, X | 1 |
1 other study(ies) available for celastrol and Dyslipidemia
Article | Year |
---|---|
Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Cytokines; Diet, High-Fat; Dyslipidemias; Energy Metabolism; Glucose Intolerance; Inflammasomes; Inflammation; Insulin Resistance; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Pentacyclic Triterpenes; Thermogenesis; Triterpenes; Weight Gain | 2021 |